Background {#Sec1}
==========

Dementia is a neurological condition that mostly occurs in individuals older than 60 years and has become a significant global problem in most developed and developing countries due to population ageing. Dementia can diminish a patient's quality of life and lead to high healthcare costs. A recent meta-analysis published by Fiest et al. \[[@CR1]\] reported that the pooled prevalence of dementia worldwide among the elderly aged 60 years and older was 4.86% (95% CI: 4.20--5.63%). In China, the most populous developing country in the world, dementia represents a serious challenge. Dementia in mainland China has been investigated by several groups and seems to be increasing, according to recent reviews \[[@CR2]--[@CR4]\]. Our group previously published a systemic review including 25 studies in 2007 \[[@CR2]\], and the review demonstrated that the pooled prevalence of dementia in the elderly population aged 60 years and older was 2.8% (95% CI: 2.5--3.1%). Wu et al. \[[@CR4]\] revealed the pooled prevalence of dementia from the 76 studies was 3.8% (95% CI: 3.4, 4.2) with the range from 0.6 to 17.2% for the population aged 60 and over in 2013. Wu et al. \[[@CR4]\] was also the first to separate mainland China into three areas (north, central and south) and to discuss the prevalence of dementia in an age-standardized pattern. The authors showed an increasing prevalence from north to south and that the discrepancy between the areas could not be explained by the differences in methodological factors, including the age range and diagnostic criteria. However, Wu et al. \[[@CR4]\] did not analyse the prevalence of dementia subtypes (primary Alzheimer's disease (AD) and vascular disease (VAD)) and did not discuss their findings in the context of chronology. This article provides a detailed study of dementia and its subtypes in mainland China up to December 2015 and attempts to identify potential factors underlying the differences between articles through a meta-regression analysis.

Methods {#Sec2}
=======

Search strategy and selection criteria {#Sec3}
--------------------------------------

Two reviewers independently searched the Cochrane Library, CBMDISK, Chongqing VIP, CNKI, PubMed and EMBASE databases up to December 2015 using 'Alzheimer's disease' or 'AD', 'vascular dementia' or 'VAD', 'dementia', and 'prevalence' or 'associated risk' or 'infection status' or 'epidemic status' or surveillance' as the major search terms. There were no language limitations, but the study did not include epidemiological studies in the areas of Hong Kong, Macao and Taiwan because these data were not easily accessible. In addition, the authors screened the reference lists of the identified articles and corresponded with the study investigators using the approach recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

The inclusion criteria were as follows: (i) case collection based on a field survey; (ii) studies published in peer-reviewed journals; (iii) the population in the investigations was 55 years and older; (in our study, data from participants below 55 years of age were omitted); and (iv) used a validated method to assess the dementia diagnosis (through both a screening phase and a diagnostic phase). The exclusion criteria were as follows: (i) studies that used the Newcastle-Ottawa scale (NOS); (ii) articles with repeated cases; (iii) articles of inferior quality or with incomplete information; and (iv) unavailable articles (i.e., reviews, comments, and abstracts).

Data extraction {#Sec4}
---------------

In the screening stage, all samples were screened using brief cognitive tests, including the Mini-Mental State Examination (MMSE), the Blessed Dementia Scale (BDS) and the Hasegawa Dementia Scale (HDS). Positive screens were identified when the samples scored below the cut-off point on one or more tests or were clinically diagnosed with dementia. In the diagnosis stage, positive screens were further diagnosed by experienced physicians with the assistance of laboratory and neuropsychological tests.

The clinical diagnostic criteria used in the 50 studies included the DSM-III (the Diagnostic and Statistical Manual of Mental Disorders, Third Edition) \[[@CR5]--[@CR7]\], DSM-III-R (the Diagnostic and Statistical Manual of Mental Disorders, Third Edition) \[[@CR8]--[@CR23]\], DSM-IV (the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) \[[@CR24]--[@CR39]\], DSM-IV-R (the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, revised) \[[@CR40]--[@CR47]\], ICD-10 (international Classification of diseases-10) \[[@CR5], [@CR13], [@CR15]\] and CCMD (Chinese Classification and Diagnostic Criteria of Mental Disorders) \[[@CR48]\]. The NINCDS-ADRDA (National Institutes of Neurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association) criteria were used to diagnose probable AD, and the NINDS-AIREN (National Institute of Neurological Disorders and Stroke and Association International pour la Recherche et 1′Enseignement en Neurosciences) criteria and the Hachinski Ischaemia Score were used to diagnose VAD. Other dementias, such as mixed dementia, dementia with Lewy bodies, Parkinson's disease with dementia, and alcoholic dementia, were defined using globally accepted criteria.

The detailed information extracted from the articles included the following: (i) basic information, including the author, type of publication and publication year; (ii) study design and tools, such as screening methods and tools, diagnostic criteria and sampling methods; (iii) characteristics of the study population, including age, location, occupation and education; and (iv) the prevalence of dementia and its subtypes.

Full manuscripts of the potentially acceptable studies were screened by two reviewers. The same two authors independently assessed the risk of bias of these nonrandomized studies using a modified version of the Newcastle-Ottawa Scale (NOS), which assesses the quality of nonrandomized studies based on design, content and ease of use to facilitate the task of incorporating quality assessments into the interpretation of meta-analytic results. Disagreements were resolved via consensus after discussion with a third author.

Statistical analysis and heterogeneity {#Sec5}
--------------------------------------

The prevalence was calculated with the variance-stabilizing double arcsine transformation and weighted towards 50% to include studies with a low dementia prevalence \[[@CR49]\]. The 95% confidence intervals (CIs) were calculated using the Wilson method \[[@CR50]\]. Two-sided *p* values \< 0.05 were considered significant. A *p* value of Cochrane's Q test \< 0.1 or an I^2^ \> 50% was defined as indicating significant heterogeneity between studies. Due to the high heterogeneity observed (I^2^ \> 75%), random effects models were used for the pooled statistical analyses. To identify factors that influenced the prevalence of dementia and its subtypes (AD and VAD), the characteristics of the cases, including gender, age, occupation, educations, and residence, were divided into diverse groups for analysis. We also performed subgroup analyses based on the specific region or publication year of the study. Publication bias was estimated using Egger's test.

Due to the high heterogeneity, we further investigated the potential sources of heterogeneity via a meta-regression analysis. All studies were allocated into diverse groups according to their potentially relevant characteristics. The suspected factors were analysed using a univariate model including the (i) publication year (before and including the year 2000 versus after 2000), (ii) geographical region (north China versus central and south China), (iii) living area (urban only versus rural only and mixed), (iv) sample size (\> 3000 versus ≤3000), and (v) diagnostic method (DSM−/IV/IV-R versus others). Furthermore, we subdivided the geographical regions/diagnostic methods into 7/4 groups, respectively, and analysed these factors using a multivariate analysis model.

All the analyses were performed with R version 3.3.3 (Microsoft Corporation, Redmond, WA, USA). The PRISMA guidelines were followed throughout the entire process.

Data availability {#Sec6}
-----------------

All data generated or analysed during this study are included in this published article (and its Supplementary Information files).

Results {#Sec7}
=======

Study inclusion {#Sec8}
---------------

We strictly screened 1230 studies in a step-by-step manner based on the inclusion criteria. Ultimately, 51 surveys from 50 articles were included after the search process, including 49 studies that reported one survey and 1 study that reported two surveys due to differences in nationality (Han/Kazak nationalities) **(**Fig. [1](#Fig1){ref-type="fig"}**)**.Fig. 1The detailed search process

Descriptive statistics {#Sec9}
----------------------

A total of 166,068 people aged 55 years or older (including 78,603 males and 87,465 females) were gathered from all 51 surveys; the publication year ranged from 1985 to 2015. The locations of all 51 surveys were distributed into 3 areas, including 7 regions (north area: north/northeast/northwest China; central area: central/east China; and south area: south/southwest China) and then subdivided into 23 provinces and municipalities. Detailed information regarding the study characteristics is shown in Table [1](#Tab1){ref-type="table"}.Table 1Characteristics of the included studies included in this articlestudyLocationUrban/ruralSurvey dateSubject no.(M/F)ADVADDementiaAge rangeDiagnostic criteriaNewcastle-Ottawa scaleChen changhui1992 \[[@CR9]\]BeijingC1986.1--1986.65172(2385/2787)102639≥60DSM-III8gao surong1989 \[[@CR10]\]BeijingC1986.4--1986.6906(409/497)92435≥60DSM-III8gao zhixu 1993 \[[@CR11]\]ShanghaiC + R1990.10--1990.123779(1499/2280)11932159≥60DSM-III-R9wang dao1996 \[[@CR12]\]ShanghaiC + R19911515(610/905)27433≥55DSM-III-R8mao ruihe1993 \[[@CR13]\]FujianC + R1992.6--1992.91982(787/1195)292258≥60DSM-III-R9xue guanhua1997 \[[@CR7]\]GuangdongC + R19943285(1579/1706)231847≥60DSM-III-R9tang mouni1999 \[[@CR14]\]SichuanR19945987(2653/3334)8611104≥65DSM-III-R8li zengjin1997 \[[@CR15]\]BeijingC1994.11--1995.51027(372/655)382563≥60DSM-III-R8chen zhanying1998 \[[@CR16]\]XinjiangC + R1995.1--1995.32687(1380/1307)113748≥55DSM-III8lv shuchen1998 \[[@CR51]\]ZhejiangC1995.10--1996.61689(823/866)10117119≥60DSM-III-R8zhang jingli1998 \[[@CR25]\]BeijingC1995.12--1996.121243(760/483)171229≥60DSM-III-R7tang zhe2002 \[[@CR52]\]BeijingC + R1996--19982788(1356/1432)14043208≥60DSM-III-R9wang tianxiang1999 \[[@CR17]\]AnhuiC + R19972749(998/1751)10927143≥65ICD-109zhou fen2001 \[[@CR26]\]ShanghaiC + R199715,910(7148/8762)34498478≥55DSM-IV9lishuran1999 \[[@CR27]\]BeijingC19971593(697/896)221540≥60ICD-107tang mouni2001 \[[@CR18]\]SichuanC + R1997.6--1998.45353(2552/2801)11020143≥55DSM-III-R9xiao zhijie1999 \[[@CR19]\]HunanC + R1997.6--1998.53287(1551/1736)472686≥55DSM-IV9qu qiumin2001 \[[@CR28]\]ShanxiC + R1997.9--1998.124850(2040/2810)10054172≥55DSM-IV9zhang zhanxing \[[@CR20]\]ShanghaiC + R19991186(597/589)11533≥55DSM-III-R9fan jianxiong2000 \[[@CR48]\]JiangsuC1999.5--1999.63268(1589/1679)311648≥60DSM-III-R9ma cui2005 \[[@CR40]\]GuangdongC + R20003780(1539/2241)12844182≥65DSM-IV9tang mouni2005 \[[@CR29]\]SichuanC + R2000.10--2001.33908(1924/1984)7818107≥55DSM-III-R9gongjianbing2002 \[[@CR53]\]HainanC + R2001.10--2001.122961(1210/1751)25939≥60CCMD-III-R9zhou kaili2002 \[[@CR21]\]ChongqingC2001.3--2001.51519(611/908)73987≥65DSM-IV-R9gao quwen2004 \[[@CR54]\]GuangdongC20021839(1727/112)224069≥60DSM-IV7yuan yefeng2005 \[[@CR30]\]JiangxiC + R2002.3--2002.42126(1053/1073)721493≥60ICD-108chen weixiong2004 \[[@CR31]\]HainanC2002.5--2002.1012,628(6193/6435)80113193≥60DSM-III-R9li wenbiao2003 \[[@CR32]\]Inner MongoliaC2002.7--2002.82324(1846/478)313162≥60ICD-107li keqing2008 \[[@CR33]\]HebeiC + R20042126(1100/1026)16652218≥65DSM-IV9huang wenyong2007 \[[@CR22]\]GuizhouC20053229(1227/2002)411864≥60DSM-IV8chen bin2009 \[[@CR55]\]FujianC2006.7--2007.42373(1039/1334)8135141≥60DSM-IV8wang hongyan2009 \[[@CR34]\]ShandongC2007618(211/407)421052≥60DSM-IV7tan jiehua2007 \[[@CR35]\]HubeiC + R2007.1--2007.123908(1924/1984)7818107≥55DSM-III-R9zheng xiuxia2010 \[[@CR41]\]BeijingC + R2007.5--2007.91756(737/1019)5769126≥60ICD-109Zhang honghui 2008 \[[@CR23]\]FujianR2007.7--2007.112696(1104/1592)13432166≥65DSM-IV8fan qinghua2011 \[[@CR36]\]ShanxiC + R20081826(1126/700)381874≥60DSM-IV9wang ying2010 \[[@CR37]\]LiaoningC2008.1--2009.12100(1136/964)7647143≥60DSM-IV-R7gao ying2009 \[[@CR38]\]ShanxiC2008.3--2008.12312(163/149)29837≥65DSM-III-R7ma yong 2013 \[[@CR56]\]ShanghaiC20102442(1130/1312)10189190≥65DSM-IV8kang meiyu2011 \[[@CR42]\]HebeiC + R2010.1--2010.83632(1937/1695)17757263≥60DSM-IV9meng xinling2014 \[[@CR39]\]XinjiangC + R2010.6--2012.82532(1221/1311)14968237≥55DSM-IV9meng xinling2014 \[[@CR39]\]XinjiangC + R2010.6--2012.81078(497/581)482176≥55DSM-IV9lao meili2011 \[[@CR43]\]HainanC + R2010.7--2010.87665(3509/4156)11148159≥55HDS9sun hongxian2012 \[[@CR44]\]ShanghaiC2010--20111472(666/806)561879≥60DSM-IV-R9cheng qi2013 \[[@CR57]\]ShanghaiR20111472(665/807)5321157≥60DSM-IV-R9ji yong2015 \[[@CR58]\]TianjinR2011--20125578(2482/3096)2999684≥60DSM-IV8tang jiangping2014 \[[@CR45]\]HunanC + R2011.10--2012.1210,026(4845/5181)27585395≥55DSM-IV8wei chongjuan2014 \[[@CR46]\]TianjinC20121324(1078/246)2828497≥55DSM-IV-R9ding ding 2014 \[[@CR47]\]ShanghaiC20123141(1438/1703)1132572≥60DSM-IV-R7li haihong2015 \[[@CR59]\]GuangxiC2012.6--2014.3889(389/500)381859≥60DSM-IV-R9li chonghui2015 \[[@CR60]\]TianjinC20142532(1091/1441)14459228≥60DSM-IV-R9

The quality scores of the studies were 7--9 (average = 8.412) when evaluated using the Newcastle-Ottawa quality assessment criteria; the score components for all 50 individual studies are shown in Additional file [1](#MOESM1){ref-type="media"}.

Analysis of outcomes {#Sec10}
--------------------

### Prevalence of dementia {#Sec11}

All 51 surveys provided the number of patients with dementia, which was divided by the different pathological subtypes (AD, VAD and others). Estimates of the dementia prevalence ranged from 0.75--11.86%, and the pooled prevalence of dementia was 4.03% (95% CI: 3.46--4.70%). The pooled prevalence of AD/VAD was 2.44% (95% CI: 2.06--2.89%)/1.09% (95% CI: 0.91--1.31%), with ranges from 0.19--9.29%/0.18--3.64%, respectively (see Additional file [2](#MOESM2){ref-type="media"}). For other dementia subtypes, such as Parkinson's disease, the prevalence (0.09% \[0.07%; 0.12%\]) was much smaller than that for AD/VAD, as detailed in Additional file [3](#MOESM3){ref-type="media"}.

The prevalence of dementia depending on age (55--59, 60--64, 65--69, 70--74, 75--79, 80--84, 85--89, 90--94, and \> 95 years; males and females were analysed separately for each age group) is shown in Additional file [4](#MOESM4){ref-type="media"}**.** The prevalence of dementia and its subgroups (AD and VAD) increased progressively with increasing age in both males and females.

Other factors, such as sex (male and female), education level (illiterate, primary school, junior high school, senior high school and college), residence (city and rural), and occupation (worker, farmer, officer and housewife) were calculated and presented in Additional file [5](#MOESM5){ref-type="media"}**.** The prevalence of AD was significantly higher in females (3.24, 95% CI: 3.08--3.41%) than in males (1.58, 95% CI: 1.46--1.70%), which was not observed for VAD. The prevalence decreased progressively with increasing education level for both AD and VAD. The prevalence rates of AD/VAD were significantly lower in the college group (0.68, 95% CI: 0.31--1.48%)/(0.67, 95% CI: 0.34--1.32%) than in the illiterate group (6.06, 95% CI: 4.08--8.91%)/(2.42, 95% CI: 1.57--3.71%). The prevalence of dementia was not significantly different between the city and rural groups. The housewife group had a much higher prevalence of AD than the other occupations, but the result was biased by gender, because the term "housewife" inherently referred to females.

### Subgroup analysis {#Sec12}

The subgroup analysis based on region showed that the prevalence of AD decreased progressively from north China to south China. The prevalence rates in the northeast/north/northwest areas of north China were 3.62%/3.08%/2.63%, respectively, which were higher than the prevalence rates in the central area (central/east China: 2.25%/3.41%, respectively). The south area (southwest/south China: 2.24%/2.25%, respectively) had the lowest prevalence. The prevalence of VAD in the north region (northeast/north/northwest China: 2.24%/1.62%/1.51%, respectively) was higher than the prevalence in the central and south regions (central/east/southwest/south China: 0.64%/0.99%/0.45%/1.02%, respectively) (see Additional file [6](#MOESM6){ref-type="media"}).

We divided the studies into 6 groups according to the publication year (1985--1990, 1991--1995, 1996--2000, 2001--2005, 2006--2010 and 2010--2015) and found that the prevalence rates of AD/VAD were 0.87%/1.04, 1.58%/0.79, 2.09%/0.76, 1.88%/0.94, 3.84%/1.61, and 3.77%/1.49%, respectively (see Additional file [7](#MOESM7){ref-type="media"}**)**.

### Publication bias {#Sec13}

The *p*-value of Egger's test was 0.02972. The asymmetric funnel plot showed that publication bias existed between the studies **(**Fig. [2](#Fig2){ref-type="fig"}**)**.Fig. 2The asymmetric funnel plot from Egger's test

### Meta-regression {#Sec14}

The outcomes of the univariate meta-regression analysis are presented in Additional file [8](#MOESM8){ref-type="media"}: Table S8 (online)**.** Depending on the univariate meta-regression results, the prevalence rates of dementia/AD/VAD were higher in studies in which the publication year was after 2000 (*p* = 0.0002/0.0002/0.0062), and the sample size was greater than 3000 (*p* \< 0.0001/0.0318/0.0025). The prevalence of dementia/AD/VAD was not significantly different according to the living area (neither city versus city plus rural areas nor city versus rural areas) or the diagnostic method (DSM-III/IV/IV-R vs. others). However, the prevalence of VAD was higher in studies from north China (*p* \< 0.0001), which was not observed for dementia or AD. Then, we added two risk factors (geographical region and diagnostic criteria) to the multivariate analysis model (Table [2](#Tab2){ref-type="table"}). When we set central China as the reference geographical region, only three groups (north China/northeast China/northwest China) showed higher prevalence rates of VAD (*p* = 0.0006/0.0009/0.0046), which was not observed in dementia or AD. When we set DSM-III/III-R as the reference diagnostic criteria, studies in which DSM-IV/IV-R were used had a higher prevalence of dementia/AD/VAD (p \< 0.0001/\< 0.0001/0.0008) in the multivariate meta-regression analysis (see Additional file [8](#MOESM8){ref-type="media"}**)**.Table 2Multivariate analysis (random effects model) of the meta-regressionMeta-regression Coefficient (%)95% CIPDementia Geographical region  East China0.2965−0.4241-1.01710.4199  North China0.3952−0.3414-1.13190.2930  South China0.0179−0.7462-0.78200.9634  Central China (ref.)------  Northeast China0.7058−0.3754-1.78710.2007  Northwest China0.2726−0.6063-1.15140.5433  Southwest China−0.1598−0.9669- 0.64720.6979 Diagnostic criteria  DSM-III/III-R (ref.)------  DSM-IV/IV-R0.69300.3919--0.9940\< 0.0001  ICD-100.3147−0.2421-0.87150.2680  HDS−0.3239−1.3516-0.70370.5367AD Geographical region  East China0.4463−0.4022-1.29480.3025  North China0.3469−0.5217-1.21550.4338  South China0.0150−0.8853-0.91540.9739  Central China (ref.)------  Northeast China0.5119−0.7663-1.79000.4325  Northwest China0.1775−0.8587-1.21370.7371  Southwest China0.0175−0.9328-0.96790.9711 Diagnostic criteria  DSM-III/III-R (ref.)------  DSM-IV/IV-R0.74780.4020--1.0935\< 0.0001  ICD-100.2641−0.3752-0.90340.4181  HDS−0.1414−1.3096-1.02680.8125VAD Geographical region  East China0.4028−0.0984-0.90410.1152  North China0.87770.3787--1.37670.0006  South China0.4186−0.1079-0.94500.1192  Central China (ref.)------  Northeast China1.23130.5023--1.96030.0009  Northwest China0.83850.2546--1.42250.0049  Southwest China0.4186−0.1079-0.94500.1192 Diagnostic criteria  DSM-III/III-R (ref.)------  DSM-IV/IV-R0.61280.2542--0.97130.0008  ICD-100.6050−0.0534- 1.26340.0717  HDS−0.2097−1.4028-0.98350.7305

Discussion {#Sec15}
==========

In this systemic review and meta-analysis, we analysed 51 surveys conducted in mainland China from 1985 to 2015. The overall estimate of the dementia prevalence was 4.03% (95% CI: 3.46--4.70%), whereas the pooled prevalence of AD/VAD was 2.44%/1.09%. The prevalence of dementia/AD/VAD was greater than that reported in a previous review \[[@CR2]\] but lower than that reported in reviews that selected studies conducted after 2000 \[[@CR3], [@CR61], [@CR62]\]; this finding was consistent with the results of a meta-regression that found that the prevalence rates of dementia/AD/VAD were significantly higher in studies published after 2000. The most common type was AD (64.6%), followed by VAD (26.8%). The proportions of AD/VAD were similar to the proportions reported in our previous study \[[@CR2]\] but much higher than those observed in United States \[[@CR63]\]. Furthermore, in some countries, such as Russia and Japan \[[@CR64], [@CR65]\], the prevalence of VAD was higher than that of AD, which might be due to the inclusion of different diagnostic criteria, ethnicities and genetic factors \[[@CR66], [@CR67]\].

The prevalence of AD followed an obviously increasing pattern from the southern and central to the northern areas of China in the subgroup analysis. The prevalence of VAD was much higher in the northern area of China, but the difference between the central and southern areas of China was not significant. However, the economic discrepancies and differences in education between these areas were not significant, because all three areas included big cities (Beijing/Shanghai/Guangzhou) and less developed provinces (e.g., Inner Mongolia /Anhui/Guangxi); this finding was consistent with a previous study \[[@CR4]\]. Air pollution is much more severe in northern China, and recent studies have shown that PM 2.5 (PM2.5 refers to atmospheric particulate matter (PM) that have a diameter of less than 2.5 μm which is an air pollutant that is a concern for people's health when levels in air are high) can injure brain structures and cognition, which may ultimately increase the prevalence of AD/VAD. In 2016, an article published by Casanova et al. \[[@CR68]\] found that long-term PM 2.5 exposure induced the loss of grey matter and white matter in older women, which could increase the prevalence of AD. Other studies confirmed that air pollution increased the prevalence of dementia \[[@CR69]--[@CR71]\], whereas some larger multi-centre studies published in *Neurotoxicology* and *Lancet* in 2017 also found that the prevalence of dementia was positively related to the level of air pollution \[[@CR72], [@CR73]\]. Therefore, we think climate environment factors and other socioeconomic factors may be potential influencing factors that require further research with well-designed studies to identify their impacts.

Chronologically, the prevalence rates of AD/VAD were higher after 2000 than before 2000. Wu et al. \[[@CR4]\] showed an increasing trend in the prevalence from 1980 to 2014, but the significance disappeared when the authors accounted for changes in methodological factors (especially the diagnostic criteria). Renewal of the diagnostic criteria for dementia has been ongoing over the past few decades. Several new criteria have been proposed, including DSM--IV/IV--R, which replaced DSM--III/III--R, as well as other older criteria.

The important influence of methodological factors was confirmed by the meta-regression analysis in this study. According to the meta-regression outcomes, studies using the DSM-IV/IV-R had a higher prevalence of dementia/AD/VAD; we suspect that the increased diagnostic level (including the updated diagnostic criteria) partially caused the chronological increases in dementia/AD/VAD.

We found that the prevalence rates of dementia/AD/VAD were negatively correlated with education level \[[@CR74]\]. A previous study by Langa et al. \[[@CR75]\] reported a significant decline in the prevalence of dementia between 2000 and 2012. The negative relationship between the prevalence of AD and education level has been generally accepted and is consistent with the results of our study. Education was confirmed to be related to the prevalence of AD by former studies based on regional cerebral blood flow \[[@CR5], [@CR58]\] and genetic status \[[@CR64]\]; thus, education may provide a reserve for the neuropath logical changes of AD, delaying the progress of its clinical manifestations. However, the mechanism underlying the relationship between VAD and education remains unknown and requires further research.

The prevalence of AD was much higher in the female group than in the male group, as previously established. However, the prevalence of VAD did not show a significant difference between the two groups, indicating that gender was not a risk factor for VAD. In the analysis of stratified prevalence based on 5--year age groups, we found a positive relationship between dementia/AD/VAD and age in both the male and female groups. Age was considered the pivotal influencing factor of dementia/AD/VAD. However, as we increased the number of elder groups to include those encompassing ages from 85 to 90 and 90+ years, their total sizes were much smaller than those of the other groups, which might have led to a magnified result. Thus, more high-quality studies are needed to confirm this outcome.

Jia et al. \[[@CR6]\] and Ji et al. \[[@CR8]\] both reported that the prevalence rates of dementia/AD were higher in rural areas than in urban areas and that education was the most important influencing factor. However, the meta-regression results from this study found no significant difference between urban, rural and mixed areas, which was consistent with the result from Wu et al. \[[@CR4]\]. The definition of urban or rural is not simple in China; simply stratifying by location is inaccurate and insufficient. Thus, more studies with stricter designs are needed in the future.

Our study has several limitations. Significant differences in the publication year, sample size and other factors were apparent, although the quality of the studies indicated their reliability. Depending on the results of the multivariate meta-regression analysis, we observed that the high heterogeneity between studies was caused by these risk factors. However, many risk factors were not considered. To obtain more reliable results, these risk factors and other potential factors should be better controlled. More information is needed from studies with identical designs in the future.

Because dementia is a serious societal problem, its prevention deserves more attention. According to the results of our study, some factors, such as air quality and education, are important for the prevention of dementia. However, more high-quality studies are required to resolve the many unknown factors related to dementia.

Conclusions {#Sec16}
===========

The prevalence of dementia/AD/VAD has increased over the past 30 years and may be affected by education level and diagnostic criteria. The prevalence of AD/VAD was higher in northern than in southern China, which warrants further study.
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================

 {#Sec17}
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AD

:   Alzheimer's disease

BDS

:   Blessed Dementia Scale

CCMD

:   Chinese Classification and Diagnostic Criteria of Mental Disorders

CIs

:   Confidence intervals

DSM-III

:   The Diagnostic and Statistical Manual of Mental Disorders, Third Edition

DSM-III-R

:   The Diagnostic and Statistical Manual of Mental Disorders, Third Edition

DSM-IV

:   The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

DSM-IV-R

:   The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, revised

HDS

:   Hasegawa Dementia Scale

ICD-10

:   International Classification of diseases-10

MMSE

:   Mini-Mental State Examination

NINCDS-ADRDA

:   National Institutes of Neurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association

NINDS-AIREN

:   National Institute of Neurological Disorders and Stroke and Association Internationale pour la Recherche et 1′Enseignement en Neurosciences

NOS

:   Newcastle-Ottawa scale

PRISMA

:   Systematic Reviews and Meta-Analyses

VAD

:   Vascular dementia
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